about
Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.A randomized, placebo controlled pilot trial of botulinum toxin for paratonic rigidity in people with advanced cognitive impairmentDeep brain stimulation: postoperative issues.Benign hereditary chorea.Health-related quality of life in Parkinson disease: correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veteransBenign hereditary chorea: clinical, genetic, and pathological findings.Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes.Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease.Insights into brain function through the examination of art: the influence of neurodegenerative diseases.Voluntary control and a wider clinical spectrum of essential palatal tremor.Falling risk factors in Parkinson's disease.A Patient-Based Needs Assessment for Living Well with Parkinson Disease: Implementation via Nominal Group Technique.Risk factors for the development of pedal edema in patients using pramipexole.Benign hereditary chorea revisited: a journey to understanding.Neurodegenerative disease and the evolution of art: the effects of presumed corticobasal degeneration in a professional artist.Development of a non-motor fluctuation assessment instrument for Parkinson disease.Long-term effect of unilateral pallidotomy on levodopa-induced dyskinesia.Motor facilitation while observing hand actions: specificity of the effect and role of observer's orientation.Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.Treatment of levodopa-induced dyskinesias with donepezil.Motor cortical stimulation for parkinsonism in multiple system atrophy.Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life.Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.Alterations of striatal neurons in benign hereditary chorea.Rapidly progressive behavioral changes and parkinsonism in a 68-year-old man.Phenylthiocarbamide (PTC) perception in Parkinson disease.
P50
Q28079852-36D81097-5E01-4F43-993C-D8B8805CC244Q28542828-D4BE558A-DD83-4B90-BE2E-7B40BB136B0EQ31047638-0F3157D9-2FD7-41BD-8D7A-03F0A9C8531CQ33874605-119CD661-4289-44B2-BC1A-4F711214E440Q34128695-9188B7A6-B85A-4E73-BAFB-7B0ED71267F9Q34218750-F85CABC7-6497-4FC0-A655-2D143A705A63Q34554855-FCF638D0-8443-4267-932D-277250D781EEQ35213394-49467A43-15DF-4AC0-AD9B-E750F60DDBFBQ35743022-9CBE5515-6616-42A3-8161-1500B8317558Q35805618-3A7EAE5F-CDFF-44B7-88E8-0F7E2B79A318Q36337260-F3741648-0DE8-4B6A-BCA7-CF12B73906A9Q36656468-A7021382-09AD-4BAB-BED5-6761EC100B39Q36786269-4CA4133C-31D9-460A-B502-0FE5AD191A2CQ36911678-CF4AF983-9655-436A-965F-1EC9EBA353C2Q38485168-A22A03CB-9778-4EF1-8C10-4267419DB812Q42861911-D6373385-E06F-4F27-81E7-BAD32005AECDQ43010084-BFCCE90A-E4C7-498D-BD49-DC82BF442BE0Q43904769-5B4B0AC7-B6A9-443C-BC75-A2FDC2C2549DQ44936936-07D55375-7F04-488F-8401-4D26D5AE9238Q46859070-FD200D33-CB22-451F-B307-F7F08C6723C3Q47379058-82EE716D-7131-4EFB-B3B0-B04131F763C6Q48101069-869906C1-BC2A-4A18-B908-1DC9D9C2DC53Q48388324-4CC959D9-D885-4711-85E9-16C86D11B02BQ48829740-794D01F1-6C47-455C-A52F-B27673695CCDQ51940870-365946A7-2B3E-4DCD-BA6E-E663EFC2DAA1Q52581994-1489DCA8-985B-446B-BCC3-0921FF78DC3A
P50
name
Galit Kleiner-Fisman
@ast
Galit Kleiner-Fisman
@en
Galit Kleiner-Fisman
@nl
type
label
Galit Kleiner-Fisman
@ast
Galit Kleiner-Fisman
@en
Galit Kleiner-Fisman
@nl
altLabel
G Kleiner-Fisman
@en
G. Kleiner-Fisman
@en
Kleiner-Fisman G
@en
Kleiner-Fisman G.
@en
Kleiner-Fisman
@en
prefLabel
Galit Kleiner-Fisman
@ast
Galit Kleiner-Fisman
@en
Galit Kleiner-Fisman
@nl
P214
931155042714872401282
P31
P7859
viaf-931155042714872401282